Vogt-Koyanagi-Harada Disease One Week after the COVID-19 Onset: A Case Report

Muto T, Sakamoto M, Machida S and Imaizumi S

Dokkyo Medical University Saitama Medical Center, Saitama, Japan
Imaizumi Eye Hospital, Japan

^*Correspondance to: Tetsuya Muto 

 PDF  Full Text Case Report | Open Access

Abstract:

Purpose: Herein, we report a case of Vogt-Koyanagi-Harada (VKH) disease in a patient after the Coronavirus Disease 2019 (COVID-19) infection. Case and Findings: A 57-year-old male patient presented to our hospital with a visual disturbance in both eyes that had started 3 weeks ago, accompanied by a headache. Four weeks prior to the presentation, the patient had tested positive for severe acute respiratory syndrome coronavirus-2, and the cough continued as an aftereffect. The Best-Corrected Visual Acuity (BCVA) was 1.0 and 0.6 in the right and left eyes, respectively. Fundoscopy demonstrated bilateral serous retinal and choroidal detachments in the left eye. Optical coherence tomography revealed bilateral serous retinal detachment and choroidal thickening. Fundus fluorescein angiography revealed multiple pinpoint leaks. This patient was diagnosed with a serous retinal detachment type of VKH disease after COVID-19. Steroid pulse therapy was immediately started, which had a good treatment response in the patient. The BCVA improved to 1.2 in the both eyes 2 months after starting the therapy. Conclusion: COVID-19 infection could be a possible trigger factor for VKH disease. Because the exact mechanism for the development of VKH disease remains unclear today, it should be elucidated urgently.

Keywords:

#

Cite the Article:

Muto T, Sakamoto M, Machida S, Imaizumi S. Vogt-Koyanagi-Harada Disease One Week after the COVID-19 Onset: A Case Report. Clin Case Rep Int. 2023; 7: 1554.